WIXOM, Mich., Jan. 27, 2012 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency and secondary hyperparathyroidism, announced today that it will hold an investor conference call on Thursday, March 1, 2012 at 8:30 a.m. ET to discuss its fourth quarter and year end 2011 results. Robert Chioini, Chairman and CEO, and Thomas Klema, CFO, will be hosting the call to review Rockwell's results. Rockwell will be releasing its earnings results on the same date. Revenue for 2011 is anticipated to be approximately $49 million and consistent with management expectations.
